Epoch Biodesign
London, England, United Kingdom
Team size: 11 - 50
Sector: Manufacturing and materials
About Epoch Biodesign
Company revenue: US$ 10 - 50 million
Investors: Ascension, BoxGroup, Lowercarbon Capital, Plug and Play, Possible Ventures
Company stage: Other
Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.